These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC; Mendoza MM; Yahr MD Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
43. Sinemet - 25/100. Med Lett Drugs Ther; 1980 Jun; 22(12):51. PubMed ID: 7374623 [No Abstract] [Full Text] [Related]
44. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
46. Individualization of levodopa therapy. Bianchine JR; Sunyapridakul L Med Clin North Am; 1974 Sep; 58(5):1071-81. PubMed ID: 4609364 [No Abstract] [Full Text] [Related]
47. Parkinsonism. Shimomura SK J Am Pharm Assoc; 1972 Jan; 12(1):29-36. PubMed ID: 4399879 [No Abstract] [Full Text] [Related]
48. Parkinson's disease: new treatments. Stewart RM Compr Ther; 1981 Apr; 7(4):38-44. PubMed ID: 7237986 [TBL] [Abstract][Full Text] [Related]
49. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor]. Omoto T Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531 [No Abstract] [Full Text] [Related]
50. [Therapy of Parkinson's syndrome]. Clemens R Dtsch Med Wochenschr; 1976 Mar; 101(11):420-3. PubMed ID: 767084 [No Abstract] [Full Text] [Related]
51. [Current drug treatment of parkinsonism]. Kistenev BA; Kadykov AS; Pivovarova VM Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394 [No Abstract] [Full Text] [Related]
52. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
53. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease]. Bermejo Pareja F; Martínez-Martín P Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135 [No Abstract] [Full Text] [Related]
54. [Considerations in the drug treatment of parkinsonism (author's transl)]. Hungerbühler JP; Regli F Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976 [No Abstract] [Full Text] [Related]
55. [Treatment of parkinsonism]. Kaste M; Iivanainen M Duodecim; 1976; 92(10):514-25. PubMed ID: 949943 [No Abstract] [Full Text] [Related]
56. [The treatment of Parkinson disease using the combination bromocriptine and levodopa]. Dufresne JJ Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793 [No Abstract] [Full Text] [Related]
57. Sinemet in Parkinson's disease: efficacy with and without food. Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604 [No Abstract] [Full Text] [Related]
58. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings. Neurology; 1989 Nov; 39(11 Suppl 2):1-106. PubMed ID: 2586761 [No Abstract] [Full Text] [Related]
59. Management of Parkinson's disease in general practice. Wilson JA Scott Med J; 1986 Apr; 31(2):132-4. PubMed ID: 3738478 [No Abstract] [Full Text] [Related]
60. [Diurnal worsening in Parkinson patients treated with levodopa]. Piccini P; Del Dotto P; Pardini C; D'Antonio P; Rossi G; Bonuccelli U Riv Neurol; 1991; 61(6):219-24. PubMed ID: 1813974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]